Prosecution Insights
Prosecution Insights
8 pending office actions • 7 clients • 7 examiners • 6 art units • 0 of 8 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (12%) |
| §103 only | 3 (38%) |
| §112 only | 2 (25%) |
| No statute on record | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JACKSON, SHAWQUIA | 2 | 78.0% | -3.4% |
| PIHONAK, SARAH | 1 | 61.0% | +43.1% |
| CHONG, YONG SOO | 1 | 43.6% | +41.4% |
| CHEN, CATHERYNE | 1 | 37.5% | +18.4% |
| ROCHELLE, CIERRA MARIE | 1 | — | — |
| ADLAM, CHANTAL PETA-GAYE | 1 | 52.3% | +25.6% |
| GONZALEZ, LUISALBERTO | 1 | 59.9% | +47.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723719 | COMPOUNDS | ROCHELLE, CIERRA MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18840761 | THERAPEUTIC COMBINATIONS FOR INFLAMMATORY CONDITIONS AND DISORDERS | CHEN, CATHERYNE | 154d overdue |
| 18564553 | METHODS OF TREATING SUBSTANCE USE DISORDERS USING MESCALINE | GONZALEZ, LUISALBERTO | 31d overdue |
| 18915730 | METHODS OF TREATMENT USING A STATIN AND A CANNABINOID | PIHONAK, SARAH | 2d overdue |
| 18845088 | THERAPEUTIC COMBINATIONS, COMPOSITIONS, AND METHODS FOR DESIGNING AND PRODUCING ENTACTOGENIC MINDSTATES | CHONG, YONG SOO | 22d |
| 18605819 | ENANTIOMERIC ENTACTOGEN COMPOSITIONS AND THEIR USE | ADLAM, CHANTAL PETA-GAYE | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Psylo Pty Ltd. | 2 |
| Indication BioScience | 1 |
| Mindstate Design Labs | 1 |
| Native Code Bio, LLC | 1 |
| Arcadia Medicine | 1 |
| Journey Colab | 1 |
| Awakn Ls Europe Holdings Limited | 1 |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| 1623 | 1 |
| 1655 | 1 |
| 1622 | 1 |
| 1624 | 1 |
| 1626 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18915730 | METHODS OF TREATMENT USING A STATIN AND A CANNABINOID | Indication Bioscience LLC | PIHONAK, SARAH | 1627 | Other | Final Rejection | 2d overdue | Pending | Oct 15, 2024 |
| 18845088 | THERAPEUTIC COMBINATIONS, COMPOSITIONS, AND METHODS FOR DESIGNING AND PRODUCING ENTACTOGENIC MINDSTATES | Mindstate Design Labs, Inc. | CHONG, YONG SOO | 1623 | §103 | Non-Final OA | 22d | Pending | Sep 09, 2024 |
| 18840761 | THERAPEUTIC COMBINATIONS FOR INFLAMMATORY CONDITIONS AND DISORDERS | Native Code Bio, LLC | CHEN, CATHERYNE | 1655 | §103 | Final Rejection | 154d overdue | Pending | Aug 22, 2024 |
| 18723719 | COMPOUNDS | Psylo Pty Ltd. | ROCHELLE, CIERRA MARIE | §101 | Non-Final OA | — | Pending | Jun 24, 2024 | |
| 18723836 | COMPOUNDS | Psylo Pty Ltd. | JACKSON, SHAWQUIA | §112 | Non-Final OA | — | Pending | Jun 24, 2024 | |
| 18605819 | ENANTIOMERIC ENTACTOGEN COMPOSITIONS AND THEIR USE | Arcadia Medicine, Inc. | ADLAM, CHANTAL PETA-GAYE | 1622 | Other | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18564553 | METHODS OF TREATING SUBSTANCE USE DISORDERS USING MESCALINE | Journey Colab Corp. | GONZALEZ, LUISALBERTO | 1624 | §103 | Non-Final OA | 31d overdue | Pending | Nov 27, 2023 |
| 18563857 | KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS | Awakn Ls Europe Holdings Limited | JACKSON, SHAWQUIA | 1626 | §112 | Non-Final OA | — | Pending | Nov 22, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial